Cancer is the second leading cause of death worldwide, with nearly 10 million deaths annually.1,2 In the U.S., approximately 1.9 million new cancer cases are expected to be diagnosed in 2021.1 Based on cancer biomarkers, the...

Much of the excitement related to digital pathology comes from the ability to rapidly move cases from one place to another. Remote access from home, speedy consultations, rapid review of archival material, and access to cases for clinical...

Join us for a complimentary joint Visiopharm & Ultivue webinar! Advanced Phenotyping of the Tumor Immune Microenvironment MAY 26, 2021 | 9:00AM (PDT) | 12:00PM (EDT) | 6:00PM (CET) Register Now Immunotherapy has transformed the...

OptraSCAN®, the leading end-to-end digital pathology solution provider announced that a research paper on ‘A Multi-Institutional Study to Evaluate Automated Whole Slide Scoring of Immunohistochemistry for Assessment of Programmed...

Flagship Biosciences has introduced a new menu of services to help drug developers more confidently define their path to success. ActionAssays is a comprehensive catalog of brightfield immunohistochemistry (IHC) assays that provide actionable...

February 12-14, 2018   |   Moscone South Convention Center   |   San Francisco, CA Triconference.com/Digital-Pathology Bristol-Myers Squibb and Genentech to Present on Benefits of Multiplex Immunohistochemistry at CHI's Digital...